MYRIAD GENETICS INC - MYGN
Sector:
Healthcare
· Industry:
In Vitro & In Vivo Diagnostic Substances
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q4 2025
· Q3 2025
Value (USD)
Total reported value ($000)
$568.1M
QoQ value delta ($000)
-$47.16M
(-7.66%)
Implied price effect (QoQ)
-14.83%
Shares
Total shares
92,279,326
QoQ shares delta
+7,158,553
(+8.41%)
Total shares held by funds (by quarter)
Market chart (MYGN)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q4 2025)
Top 25 only
Full list
Early Q1 2026 data: only 11 institutional holders reported so far. More will appear as funds file with the SEC.